Fig. 1 The sketch of the neonatal intensive care unit in Tokyo Women's Medical College Hospital. (1979)

Similar documents
Key words: Disinfectants, Gram negative rods, Bactericidal effect P. aeruginosa 1, P. fluorescens 20 P. putida 179, P. cepacia 216 P. maltophilia 227,

Fig.1 Chemical structure of BAY o 9867

1272 CHEMOTHERAPY MAR. 1975



Fig. 1 Chemical structure of DL-8280

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent


988 CHEMOTHERAPY NOV. 1971



CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote

CHEMOTHERAPY APRIL 1992 Acinetobacter calcoaceticus Staphylococcus aureus, Escherichia coli P. aeruginosa E. eoli, Klebsiella pneumoniae Serratia marc

Staphylococcus sp. K.pneumoniae P.mirabilis C.freundii E. cloacae Serratia sp. P. aeruginosa ml, Enterococcus avium >100ƒÊg/ml

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega

Key words: Neonate, Intestinal flora, Infection, Bifidobacterium

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

THE JAPANESE JOURNAL OF ANTIBIOTICS 48-8 Enterococcus avium 5Š, Corynebacterium xerosis 10Š, Corynebacterium pseudodiphtheriticum 10Š, Corynebacterium

Table1MIC of BAY o 9867 against standard strains

CHEMOTHERAPY Methicillin-resistant S.aureus(MRSA) coccus epidermidis 105 Streptococcus pyogenes E.faecali senterococcus avium Enterococcus faecium Str

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

- 1 -

HPM_442_F_TgCHG_1128

Streptococcus pneumoniae,streptococcus pyogenes,streptococcus agalactiae,neisseria gonorrhoeae,h.influenzae,moraxella subgenus Branhamella catarrharis

Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone



CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz


CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F

VOL.42 S-1


indd

CHEMOTHERAPY

CHEMOTHERAPY Proteus mirabilis GN-79 Escherichia coli No. 35 Proteus vulgaris GN-76 Pseudomonas aeruginosa No. 11 Escherichia coli ML-1410 RGN-823 Kle


The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi

Key Words: Klebsiella pneumoniae, CEP-AIS, MIC, "MBC", MIC of drugs in combination

Table 1. Antimicrobial drugs using for MIC

VOL.47 NO.5 Table 1. Susceptibility distribution of Ĉ- lactams against clinical isolates of MRSA MRSA: rnethicillin- resistant Staphylococcus aureus

semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia

Nippon Suisan Gakkaishi 64(4), (1998) Biodegradation of Raw Silk in Seawater Akihiko Nakayama,*1,*3 Yoshihiro Inoue,*2 Yozo Tahara,*2,*4 Shozo

VOL.48 NO.7 lase negative staphylococci, Escherichia coli, Klebsiella spp., Citrobacter freundii, Enterobacter spp., indole-positive Proteus, Serratia

CHEMOTHERAPY

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin


Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

CHEMOTHERAPY FEB Table 1 Background of volunteers

Core Ethics Vol.

Key words:fatty acid,plant oil,staphylococcus aureus,skin care, atopic dermatitis

Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile

VOL. 43 NO. 4

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo

VOL. 34 S-2 CHEMOTH8RAPY 913


CHEMOTHERAPY APR Fig. 2 The inactivation of aminoglycoside antibiotics by PC-904 Fig. 3 Serum concentration of PC-904 (1) Fig. 4 Urinary recover

co Kanamycin (KM), Streptomycin (SM), Fradiomycin Table 2. Comparison of antibacterial activity of 3', 4'-dideoxykanamycin B with that of other antibi

Key words: Antibodies to Leptospira, Tokyo, Uveitis


Questionnaire Survey on the Feeding Experiences of Mothers who Had Babies with Cleft Palates Ichiro YAMAMOTO Abstract : Mothers who have babies with c

VOL. 23 NO. 3 CHEMOTHERAPY 1379 Table 1 Susceptibility of clinical isolated strains to Tobramycin

Study on Application of the cos a Method to Neutron Stress Measurement Toshihiko SASAKI*3 and Yukio HIROSE Department of Materials Science and Enginee

Table 1 Bacteriae to be tested (1) Gram positive cocci Coagulase positive staphylococcus Coagulase negative staphylococcus Streptococcus pneumoniae Gr

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX


Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004


VOL.27 S-3 CHEMO THERAPY mido)-3-[[[1- (2-dimethylaminoethyl)-1H-tetrazol-5-yl] -thio] methyl]-ceph-3-em-4-carboxylic acid dihydro- S. aureus 209-P JC

VOL. 33 S-5 CHEMO THERAPY Fig. 1 Chemical structure of HAPA-B 1-N-[ (2 S)-3-Amino-2-hydroxypropiony1]-4- O-(6-amino-6 - deoxy-ƒ -D- glucopyranosyl) -6

dihydrostreptomycin(sm), sulfanilamide(sa), kanamycin(km), paromomycin(prm), fradiomycin(frm), ampicillin(apc), cephaloridine (CER), nalidixic acid(na

日本化学療法学会雑誌第58巻第4号

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin

九州大学学術情報リポジトリ Kyushu University Institutional Repository 看護師の勤務体制による睡眠実態についての調査 岩下, 智香九州大学医学部保健学科看護学専攻 出版情報 : 九州大学医学部保健学


Table 1 Characteristics of the study participants in Imari municipal hospital

日本化学療法学会雑誌第61巻第6号



Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad

日本看護管理学会誌15-2

Ⅱ. 用語の操作的定義 Ⅲ. 対象と方法 1. 対象 WAM NET 2. 調査期間 : 3. 調査方法 4. 調査内容 5. 分析方法 FisherMann-Whitney U Kruskal-Wallis SPSS. for Windows 6. 倫理的配慮 Vol. No.

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec DNA 2, , % 1.65% 1.17% 90% 9 Escherichia coli -

Key words: Streptococcus pyogenes, Streptococcus dysgalactiae subsp. equisimilis, rapid diagnosis

Key words: Surfactant, Tween, Legionella

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

02石出猛史.indd


(ABPC), Carbenicillin (CBPC), Surbenicillin (SBPC), Piperacillin (PIPC), Cephalexin (CEX), Cefaclor (CCL), Cephalothin (CET), Cefazolin (CEZ), Cefotia

2108 CHEMOTHERAPY SEPT Table 1 Antimicrobial spectrum Fig. 1

社会学部紀要 119号☆/表紙(119)

Elmore & Pohlmann Greenwood & Ramagli a b c a b c

Shigella flexneri 2a, Shigella flexneri 3a, Shigella sonnei, Salmonella, Salmonella arizonae, Citorobacter freundii, Enterobacter aerogenes, Enterobac

CHEMOTHERAPY JUNE 1986

Transcription:

Key words: neonatal intensive care unit, bacterial contamination, Pseudomonas, Stophylococcus

Fig. 1 The sketch of the neonatal intensive care unit in Tokyo Women's Medical College Hospital. (1979)

Table 1 Estimation of aerial bacteria in neonatal intensive care unit. Petri dishes containing heart infusion agar medium (Eiken) were exposed to air for 30 and 60 min., and incubated at 37 Ž. for 24 hours.

Table 2. Isolation and identification of bacteria isolated from the neonatal intensive care unit. 1) Identified as Acinetobacter. 2) Identified as Staphylococcus aureus. 3) Brushes sterilized in the autoclave were used. 4) Examined after washing by disinfectant. 5) Baby-bath tubs sterilized in the autoclave were used for each baby. 6) Disinfectant used was 0.1% benzethonium chloride (hyamin) in 1973, and 0.02% chlorhexidine gluconate (hibitane) in 1979. Table 3 Isolation and identification of bacteria from the incubators and suckling tools in the neonatal intensive care unit. 1) Identified as Acinetobacter. 2) Identified as Staphylococcus aureus

Table 4 Isolation and identification of bacteria from the fingers of doctors, nurses and helpers working in the neonatal intensive care unit. Fingers were rubbed on the medium.

Table 5 Certain bacteria isolated from the throats of new born infants and nurses. Table 6 Senstitvity to antibiotics of the Staphylococcus aureus strains isolated. 1) Identified as Staphylococcus aureus. The sensitivity was determined by the single disc (Showa yakuhin kako Co.) on the Heart infusion agar medium (Eiken).

Table 7 Sensitivity to antibiotics of the Pseudomonas aeruginosa strains isolated. The sensitivity was determined by the single disc (Showa yakuhin kako Co.) on the heart infusion agar medium (Eiken).

3) Thom, A. R., Cole, A. P. and Watrasiewicz, K.: Pseudomonas aeruginosa infection in neonatal nursery, Possibly transmitted by a breast-milk pump. Lancet, I: 560-561, 1970. 11) Wilson, M. G., Nelson, R. C., Phillips, L. H. and Boak, R. A.: New source of Pseudomonas aeruginosa in a nursery. J. A. M. A., 175: 1146-1148, 1961. 12) Sever, J. L.: Possible role of humidifying equipment in spread of infections from the new born nursery, Pediatrics, 24: 50-55, 1959. 13) Edmondson, E. B., Reinarz, C. A., Pierce, A. K. and Sandford, J. P.: Nebulization equipment, a potential source of infection in gram-negative pneumoniae. Amer. J. Dis. Child., 111: 357

360, 1966. 14) Burdon, D.W. and Whitby, J.L.: Contamination of hospital disinfectants with pseudomonas. Brit. Med. J., 2: 153-154, 1967. Analytical Examination of Bacteria in a Neonatal Intensive Care Unit Morimasa YOSHIOKA*, Kiyo SUSHIDA*, Hisao NAKANO*, Masumi YAYOSHI*, Minako ARAAKE*, Takako ITO*, Masako KONO*, Mariko WAKAI*, Kazuko YOKOTA** and Kyoko URAMOTO** Departments of Microbiology* and Pediatrics**, Tokyo Women's Medical College, Tokyo Examinations of pathogenic Escherichia coli, Staphylococcus and Pseudomonas from various objects, new-born infants and workers in the neonatal intensive care unit in the college hospital were performed in 1973 and 1979. In 1978 new nursery which equipped the clean air ventilation and pre-room for incoming person was opened in the hospital ward newly constructed and had been used for 8 months until this study. The results obtained as follows: 1. Pathogenic Excherichia coli was not isolated from any specimen. 2. Staphylococcus aureus was isolated from sink and catheters for nutrition. The isolates showed resistance to penicillin, erythromycin, and sulfoisoxasol. Staphylococcus epidermidis was isolated from fingers of all of doctors and nurses working in nursery. 3. Pseudomonas aeruginosa was isolated from sink, catheters for nutrition and thermometer and humidifier of incubators in both examinations, and also from the throats of new-born infants in 1973 and from the throats of new-born infants and nurses in 1979. The isolates showed sensitivity to gentamicin. 4. The results suggest that new-born infants and medical care takers are capable both of recieving and of mediating microbial contaminations, and also new-born infants, nurses and spots retentive of moisture are easily contaminated by Pseudomonas aeruginosa.